皮肤冠状动脉干预在儿科心脏移植后接受者与先进的CAV:延迟不可避免的
Matthew S Purlee1, John-Anthony Coppola2, Lindsey M Brinkley1
1College of Medicine, Department of Pediatrics, University of Florida, Congenital Heart Center, 1600 SW Archer Rd HD303, Gainesville, FL, 32610, USA.
Pediatric cardiology
|January 9, 2026
概括
穿皮冠状动脉干预 (PCI) 对患有晚期冠状动脉全移植血管病 (CAV) 的儿科心脏移植接受者提供了即时的好处. 这种治疗在一小群患者中显示了5年生存率为57%,没有死亡或再移植.
科学领域:
- 心脏病学 心脏病学
- 移植免疫学 移植免疫学
- 儿童心脏病学 儿童心脏病学
背景情况:
- 冠状动脉全移植血管病变 (CAV) 是小儿心脏移植接受者的移植失败的主要原因.
- 在CAV中,动脉硬性冠状动脉疾病往往呈现为扩散性,限制了治疗选择.
- 有限的数据存在于长期有效性皮肤穿冠状动脉干预 (PCI) 对CAV.
研究的目的:
- 评估PCI在患有CAV的儿科心脏移植接受者的利用和长期结果.
- 评估PCI在该人群中治疗晚期冠状动脉疾病的有效性.
主要方法:
- 对接受过PCI的儿科心脏移植接受者被诊断患有CAV的回顾性分析.
- 收集人口,移植和PCI相关数据.
- 卡普兰-梅尔生存分析,以免再移植或死亡.
主要成果:
- 这项研究包括17名接受21次PCI手术的患者,移植时的平均年龄为13.6岁.
- 从移植到第一次PCI的中位时间为7.7年.
- 在初始PCI后,五年无死亡或再移植的可能性为57%.
结论:
- 在儿童心脏移植接受者中,PCI表现出了有利的即时结果,这些接受者患有晚期CAV.
- 需要进一步的研究来优化PCI策略,并改善这一具有挑战性的患者群体的长期结果.
相关概念视频
01:28Cardiac Catheterization I: Pre-Procedure Overview
1.0K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
1.0K
01:29Cardiomyopathy V: Interprofessional Care
331
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
331